Incannex Healthcare INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Incannex Healthcare Inc. Director Troy Valentine was granted 11.3 million restricted shares under the company's 2023 Equity Incentive Plan, vesting through 2027.
NASDAQ
Incannex Healthcare Inc. Director Robert Clark was granted 1,686,956 shares of common stock under the company's 2023 Equity Incentive Plan.
NASDAQ
Incannex Healthcare Inc. Director Peter Widdows was granted 1,686,956 shares of restricted stock under the company's 2023 Equity Incentive Plan.
NASDAQ
Incannex Healthcare Inc.'s CFO, Treasurer, and Secretary, Joseph Swan, was granted 869,565 shares of restricted common stock under the company's 2023 Equity Incentive Plan.
NASDAQ
Incannex Healthcare Inc. CEO and President Joel Latham was granted 22.6 million restricted shares under the company's 2023 Equity Incentive Plan.
NASDAQ
Incannex Healthcare Inc. Director George Anastassov acquired 1,686,956 shares of common stock through a restricted stock grant, increasing his beneficial ownership.
NASDAQ
Luigi M. Barbato, Chief Medical Officer of Incannex Healthcare, acquired 100,476 restricted stock units on October 23, 2024, which vest over three years.